Clinical Trial Update: A Multicenter Randomized Open-label Study of Diammonium Glycyrrhizinate Enteric-coated Capsule Plus DXM Versus DXM in Treatment of ITP [Phase 2]

View source ↗

Summary

A Phase 2 multicenter randomized open-label trial compares diammonium glycyrrhizinate enteric-coated capsules plus dexamethasone versus dexamethasone alone in t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Diammonium Glycyrrhizinate Enteric-coated Capsule (diammonium glycyrrhizinate)

Snippet

Sponsor: Shandong University | Conditions: Immune Thrombocytopenia | Phase 2 | Status: ACTIVE_NOT_RECRUITING